SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001640455-23-000042
Filing Date
2023-03-27
Accepted
2023-03-27 14:11:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9 sc14d-9c03272023.htm SC 14D9 23782
2 EX-99.1 jnceexhibit9911.htm EX-99.1 22592
3 image_1.jpg GRAPHIC 11145
  Complete submission text file 0001640455-23-000042.txt   63379
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filed by) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-89831 | Film No.: 23763979
SIC: 2836 Biological Products, (No Diagnostic Substances)